Schonfeld Strategic Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $35.6M | Buy |
|
|||||
|
2021
Q1 | $16.5M | Buy |
|
|||||
|
2020
Q4 | $13.1M | Buy |
|
|||||
|
2020
Q3 | $1.64M | Sell |
|
|||||
|
2020
Q2 | $2.75M | Buy |
|
|||||
|
2020
Q1 | $1.37M | Buy |
|
|||||
|
2019
Q4 | $1.08M | Sell |
|
|||||
|
2019
Q3 | $5.35M | Buy |
|
|||||
|
2019
Q2 | $1.14M | Buy |
|
|||||
|
2019
Q1 | $267K | Sell |
|
|||||
|
2018
Q4 | $2.07M | Sell |
|
|||||
|
2018
Q3 | $5.73M | Buy |
|
|||||
|
2018
Q2 | $4.34M | Sell |
|
|||||
|
2018
Q1 | $4.29M | Buy |
|
|||||
|
2017
Q4 | $3.89M | Buy |
|
|||||
|
2017
Q3 | $3.57M | Buy |
|
|||||
|
2017
Q2 | $1.77M | Sell |
|
|||||
|
2017
Q1 | $2.06M | Sell |
|
|||||
|
2016
Q4 | $4.42M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $5.46M | Buy |
|
|||||
|
2016
Q1 | $418K | Buy |
|